Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Ritlecitinib improves hair regrowth in alopecia areata without increasing adverse risks.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Personalized sonidegib dosing can effectively treat Gorlin-Goltz syndrome with fewer side effects.

Imatinib can cause hair loss due to lichen planopilaris.

Tofacitinib and baricitinib are similarly effective and safe for alopecia areata, but baricitinib works faster.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

Ritlecitinib helps regrow hair in people with alopecia totalis and universalis and is safe to use.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Ritlecitinib was generally well tolerated in children with alopecia areata.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Physcion may help treat hair loss by blocking an enzyme linked to baldness.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Tofacitinib taken by mouth helps treat hair loss in children.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.

Baricitinib therapy helped many patients with severe alopecia regrow hair after 52 weeks.

BMS-470539 reduces skin fibrosis and inflammation.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

Ritlecitinib effectively treats alopecia areata and is well-tolerated.

Clascoterone 1% cream is a promising new treatment for acne.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Isoalantolactone promotes hair growth by activating specific cell pathways.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.